Literature DB >> 14967770

Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes.

Jaume Sastre-Garriga1, Mar Tintoré, Alex Rovira, Carlos Nos, Jordi Río, Alan J Thompson, Xavier Montalban.   

Abstract

BACKGROUND: Barkhof criteria have been adopted to demonstrate dissemination in space in the new multiple sclerosis diagnostic criteria because of their high specificity for predicting conversion to multiple sclerosis. One of the 4 Barkhof criteria is the presence of an infratentorial lesion. In clinically isolated syndromes (CIS) of the brainstem (CISB), the infratentorial criterion does not demonstrate dissemination in space, raising the possibility that the criteria may be less specific in CISB, as compared with specificity in other CIS, in which all 4 criteria demonstrate dissemination in space.
OBJECTIVE: To compare the validity indices of Barkhof criteria in CISB with those in other CIS.
DESIGN: Inception cohort with median follow-up of 34 months for CISB and 40 months for other CIS.
SETTING: Institutional ambulatory referral center. PATIENTS: A sample of 51 patients with CISB and 102 patients with other CIS (46 with myelitis and 56 with optic neuritis) was analyzed. Barkhof criteria, with a cutoff of 3 of 4, were applied to magnetic resonance imaging performed at baseline. Four combinations each containing 3 parameters were also applied, with a cutoff of 2 of 3. MAIN OUTCOME MEASURE: Specificity of unmodified Barkhof criteria and of the 4 combinations to predict conversion to clinically definite multiple sclerosis.
RESULTS: The specificity of the criteria in CISB was 61% against 73% in other CIS. The combinations that retained the infratentorial lesion parameter had lower specificities in the CISB group; in analysis of the group with other CIS, no such differences were found.
CONCLUSION: The infratentorial lesion criterion is responsible for the lower specificity of Barkhof criteria in CISB.

Entities:  

Mesh:

Year:  2004        PMID: 14967770     DOI: 10.1001/archneur.61.2.222

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.

Authors:  Jaume Sastre-Garriga; M Tintoré; C Nos; C Tur; J Río; N Téllez; J Castilló; A Horga; H Perkal; M Comabella; A Rovira; X Montalban
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 2.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

3.  Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.

Authors:  Mio Nakamura; Mark Morris; Mirela Cerghet; Lonni Schultz; Stanton Elias
Journal:  Int J MS Care       Date:  2014

4.  Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States.

Authors:  Mahboubeh Fereidan-Esfahani; Paul A Decker; Jeanette E Eckel Passow; Claudia F Lucchinetti; Eoin Patrick Flanagan; William Oliver Tobin
Journal:  Eur J Neurol       Date:  2021-12-09       Impact factor: 6.089

5.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Authors:  Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2009-04-21       Impact factor: 9.306

6.  Cluster-tic syndrome as the initial manifestation of multiple sclerosis.

Authors:  V González-Quintanilla; A Oterino; M Toriello; C de Pablos; Y Wu; E de Marco; J Pascual
Journal:  J Headache Pain       Date:  2012-04-28       Impact factor: 7.277

Review 7.  MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Authors:  Massimo Filippi; Maria A Rocca; Olga Ciccarelli; Nicola De Stefano; Nikos Evangelou; Ludwig Kappos; Alex Rovira; Jaume Sastre-Garriga; Mar Tintorè; Jette L Frederiksen; Claudio Gasperini; Jacqueline Palace; Daniel S Reich; Brenda Banwell; Xavier Montalban; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

Review 8.  Coexistence of systemic lupus erythematosus and multiple sclerosis. A case report and literature review.

Authors:  Elisa Carolina Jácome Sánchez; María Ariana García Castillo; Victor Paredes González; Fernando Guillén López; Edgar Patricio Correa Díaz
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-04-08

9.  A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings.

Authors:  Luis de Santiago; E M Sánchez Morla; Miguel Ortiz; Elena López; Carlos Amo Usanos; M C Alonso-Rodríguez; R Barea; Carlo Cavaliere-Ballesta; Alfredo Fernández; Luciano Boquete
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

10.  How much medicine do spine surgeons need to know to better select and care for patients?

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.